← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

12,081

Price

$0

Filed

Jun 3

Insider

Name

Greenstreet Yvonne

Title

Chief Executive Officer

CIK

0001446125

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-30

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

12,919

Footnotes

The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 12, 2024. | Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program. | This stock option was fully vested and exercisable as of February 26, 2024. | This stock option was fully vested and exercisable as of December 1, 2021.

Filing Info

Accession No.

0001735276-25-000075

Form Type

4

Issuer CIK

0001178670

Greenstreet Yvonne's History

Date Ticker Type Value
2026-03-04 ALNY $43K
2026-03-04 ALNY $41K
2026-03-04 ALNY $88K
2026-03-04 ALNY $118K
2026-03-04 ALNY $143K
2026-03-04 ALNY $315K
2026-03-04 ALNY $112K
2026-03-04 ALNY $86K
2026-03-02 ALNY A $0
2026-03-02 ALNY $65K

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06